Introduction
The hepatitis delta virus (HDV) causes acute and chronic liver disease in association with the hepatitis B virus (HBV); HDV requires the HBV surface antigens as an essential coat component (Bonino et al., 1986; Rizzetto et al., 1980) . Co-infection or superinfection with HDV increases the severity of liver disease compared to infection with HBV alone (Rizzetto, 1983) . Although HDV is unique among the known viral agents of animals, its genome has certain properties in common with the plant viroid and viroid-like satellite RNAs: (i) the HDV genome is 1679 nucleotides in length and so is relatively small; (ii) it consists of covalently closed, circular ssRNA with extensive regions of intramolecular complementarity, theoretically allowing the RNA to adopt a t Present address : Institute of Liver Studies, King's College School of Medicine and Dentistry, Bessemer Road, London SE5 9PJ, U.K. collapsed, ds rod-like secondary structure, in which approximately 70% of bases are paired (Kuo et al., 1988a; Wang et al., 1986) ; (iii) it replicates by a rolling circle mechanism to give oligomeric RNA intermediates of opposite polarity, which self-cleave into circular monomers (Kuo et al., 1988b; Sharmeen et al., 1988) . Cells infected with HDV have been estimated to contain around 300000 copies of the viral genome (Chen et al., 1986) . Unlike viroids, which do not encode any proteins, HDV expresses a single protein, the delta antigen (Ag). This protein is encoded by an open reading frame on the antigenomic strand and, as a result of an RNA editing event, it exists in two forms with Mrs of 24K and 27K, the larger protein possessing an additional 19 amino acids at its C terminus (Bergmann & Gerin, 1986; Luo et al., 1990; Zheng et al., 1992) . The delta Ag is a nuclear phosphoprotein with RNA-binding activity (Chang et al., 1988) which plays a central role in the HDV replication cycle. The small antigen (P24) is responsible for transport of the RNA into the nucleus (MacNaughton et at., 1991) and is essential for HDV RNA replication in transfected cells in culture (Kuo et (Samuel, 1979) . The subunit of eIF2 is then phosphorylated, leading to the inhibition of protein synthesis (Hovanessian, 1989 
Methods
Plasmids. The delta Ag-and RNA-expressing constructs used the expression vector pSVL (Pharmacia) and were kindly provided by Dr J. Taylor (Fox Chase Cancer Center, Philadelphia, Pa., U.S.A.). As previously described (Kuo et al., 1989) , cloned HDV cDNAs were inserted into the vector to create an infectious trimer of unit-length HDV, pSVL.D3 and a eDNA, of less than unit length, expressing antigenomic RNA that synthesized the small delta Ag, pSVL.Ag-S. Stable transfection of cells with pSVL.D3 leads to the expression of genomic and antigenomic HDV RNAs and both the small and large forms of delta Ag (Kuo et al., 1989) . Constructs expressing an mRNA containing the full-length HDV RNA, but not expressing the delta Ag, were derived from pSVL. D2M, which contains a dimer of the complete genome except for the deletion of 2 bp at positions 1434 and 1435 [using the notation for the 1679 base genome previously described by Kuo et al. (1988b) ]. A unit-length fragment was excised with XbaI and cloned into the expression vectors pRC.CMV and pRC.RSV (Invitrogen) to give plasmids pCMV.D2M and pRSV.D2M respectively.
Cells, transfections and assays. Human hepatoma cells (Huh7), fibrosarcoma cells (HT1080), mouse fibroblast (C127) and HeLa cells were grown as monolayers in Dulbecco's modified MEM supplemented with 10 % fetal calf serum, 1 mM-glutamine and penicillin/streptomycin and grown at 37 °C in an atmosphere of 5 % CO 2. Cultures were split at a ratio of 1:3 and the medium was changed twice weekly. DNA transfections, using a calcium phosphate procedure, were performed as previously described (Porter et al., 1988) . Stable transfectants were generated by cotransfection of pTKneo and subsequent selection in a medium containing 400 gg/ml G418. Colonies were ring-cloned and clones expressing delta Ag and/or HDV RNA were then identified by immunoblotting and RNase protection assay (see below). Chloramphenicol acetyltransferase (CAT) assays were performed in HeLa cells as previously described (Porter et al., 1988) . Briefly, cells were plated on six-well plates at a concentration of 104 cells/well and 24 h later were cotransfected with an IFN-inducible CAT construct, 474.1. I.CAT, which contains the IFN-stimulated response element from the IFN-c~-inducible 6-16 gene (1 lag/well), and either pSVL.Ag-S or the vector pSVL (2 lag/well). IFN-~ and IFN-7 at 1000 IU/ml were applied after 12 h. Cell lysates were harvested and assayed 36h later using the method of Sleigh (1986) .
IFN treatment. Cells were treated with a highly purified mixture of eIFNs (Wellferon, 1.5 x 108 IU/mg protein; provided by Wellcome Research Laboratories) at 1000 IU/ml for the time stated. Recombinant IFN-y (4 x 107 IU/mg protein) was supplied by Dr G. Adolf (Ernst Boehringer Institut fiir Arzneimittelforschung, Vienna, Austria).
Poly(rI) .poly(rC) treatment.
Cells were treated by a modification of the method of Zinn et al. (1983) . Monolayers were washed twice in serum-free medium and then poly(rI), poly(rC), at a final concentration of 0.1 mg/ml, was applied in serum-free medium for 2 to 6 h. The cells were then harvested for RNA preparation.
RNase analyses. Total cellular RNA was prepared from monolayer cells by NP40 lysis and phenol-chloroform extraction. RNase protection (Sambrook et al., 1989) was performed, using probes labelled with [c~-32P]UTP and synthesized from SP6 transcription vectors, containing PKR, 2',5rA synthetase and ~-actin cDNA inserts, and gave protected fragments of 300, 220 and 130 nucleotides respectively. An SP6 construct containing a eDNA to IFN-/~ protected 270 nucleotides and was kindly provided by Dr S. Goodbourn (Imperial Cancer Research Fund). Probes for HDV RNA protected 95 bases of antigenomic RNA (from the EcoRI site at position 1427 to the StuI site at 1332) and 155 bases of genomic RNA (from XhoI at 1272 to EeoRI at 1427). Probes were labelled to an activity of 2 x 10 ~ c.p.m, per lag of input DNA. An activity of 3 x 105 c.p.m, for the probe was used in each assay, along with 10 lag of cytoplasmic RNA. Probes were present at 100-to 1000-fold excess, demonstrated by running 3 x 103 c.p.m, of free probe on the same gel. To confirm that the results provided an accurate quantification of the target RNA, each probe was tested with positive control samples, containing 5, 10 and 20 gg of total RNA, and the density of bands on autoradiographs was compared to the amount of input RNA. Northern blotting (i0 lag of R N A per sample) was performed as previously described (Porter et al., 1988) .
Immunostaining. Cells from Huh7 clones transfected with pSVL. D3 were fixed with acetone for 20 rain at -2 0 °C. They were then incubated for 30 min with polyclonal rabbit antiserum raised against a truncated delta Ag (amino acids 13 to 64) fused with the first 98 amino acids of MS2 polymerase (Saldanha et al., 1990 ) at a dilution of 1:50 in PBS containing 5 % fetal calf serum. After washing three times in PBS, the second layer of swine anti-rabbit immunoglobulin conjugated with fluorescein isothiocyanate (Dako) was applied at a 1 : 20 dilution and incubated at 37 °C for 30 min. The stained cells were washed twice in PBS and once in water and mounted.
Immunoblotting. Protein samples were subjected to electrophoresis on 12% acrylamide gels by the method of Laemmli (1970) and transferred electrophoretically to PVDF membrane (Immobilon-P; Millipore) according to manufacturer's instructions. The delta Ag was detected using a rabbit polyclonal antiserum, a peroxidase-labelled goat anti-rabbit antiserum (Jackson Immunoresearch) and 3,Ydiaminobenzidine (Sigma) as the peroxidase substrate.
Antiviral assays. Cells seeded in 96 well microtitre plates at a concentration of 5 x 10 a per well were incubated for 18 h at 37 °C. They were then treated with serial dilutions of IFN-0¢ and IFN-?~ for 24 h and challenged with serial dilutions of encephalomyocarditis virus (EMC) and Semliki Forest virus (SFV). Protection from the cytopathic effects of each virus was scored after 24 to 48 h. Each assay was repeated three times.
PKR assays. These were performed as previously described (Silverm a n et al., 1982a). Briefly, 3 lal extracts from cells treated with IFN-c¢ at 1000 I U / m l for 24 h were incubated in a final volume of 10 lal containing 10 mM-MgC12, 100 laM-ATP (unlabelled) and 1.0 laCi [7-3ZP]ATP ( > 5000 Ci/mmol), with or without 1 lag/ml poly(rI). poly(rC). The samples were incubated at 30 °C for 15 min and analysed on 12% SDS~polyacrylamide gels.
Results

Effect of IFN-~ and IFN-~, on expression of l i d V RNA and delta Ag in Huh7-and HTlO80-derived clones
Clones of cells selected in G418 following transfection with pSVL.D3 (see Methods) were ring-cloned and analysed, by immunostaining and immunoblotting, for expression of delta Ag. Several delta Ag-expressing Huh7-derived clones were identified. One of these, H7. D (referred to originally as 1.2D; Cheng et al., 1992) and two similarly isolated HT1080-derived clones, HT. D3(1) and HT. D3(2), were used in this study. HDV genomic and antigenomic RNAs were detected by an RNase protection assay in both cell lines and shown to be expressed at a constant level over time. Similarly, the level of expression of the small and large forms of delta Ag was constant with time. The effect of treatment of H7.D with IFN-a and IFN-7 for between 1 and 7 days on the level of HDV RNA and delta Ag was determined ( Fig. 1 and 2 ). There was no significant variation in the level of either following IFN treatment. Similarly, the level of HDV RNA and delta Ag in the fibrosarcomaderived cell lines was not affected by IFN treatment (data not shown). 
Expression of lFN-inducible genes
The response of several IFN-inducible genes to IFN-~ and IFN-y in H7. D cells was determined by an RNase protection assay or Northern transfer. The 2',5'A synthetase and P K R genes, which are both predominantly IFN-~-inducible, respond normally to I F N (Fig.  3 a and b ) and the induction of the IRF-1 gene (the IFN-7 response of which is known to be primary) was also normal in H 7 . D (Fig. 3c) . The 6-16, 9-27 and //2-microglobulin genes, which are IFN-~-and IFN-y- inducible, also responded normally to I F N (data not shown). For the HDV-expressing fibrosarcoma cell lines, inducibility of the 6-16 and 9-27 genes by IFN-~ and IFN-y was also normal.
To determine the effect of the delta Ag on expression from an IFN-inducible reporter gene construct, HeLa ceils were transfected with the plasmid pSVL. Ag-S and the IFN-~/7-inducible CAT construct 474.1.1. CAT in a molar ratio of 4: 1. As a control, the CAT construct was cotransfected with the expression vector pSVL in the same molar ratio. Experiments were performed in triplicate. Compared to controls, the delta Ag-expressing construct had no effect on IFN-induced CAT expression; IFN-~ treatment resulted in an 8-to 10-fold induction of CAT activity with both control and test constructs and IFN-y resulted in a 2"5-to 3-fold induction. Delta Ag expression in the transfected HeLa cells was confirmed by immunoblotting.
Antiviral assays
To assess the integrity of the antiviral response in HDVtransfected hepatoma and fibrosarcoma cells, antiviral assays were performed using EMC and SFV. For EMC at a titre of 10 p.f.u./cell, IFN-~ at 6 I U / m l protected 50% of cells from lysis in both H T . D 3 and parental HT1080. Huh7 and H 7 . D both required IFN-~ at 50 I U / m l for 50% protection. Assays on SFV also showed that the ability of the parental and HDVexpressing cell lines to mount an antiviral response to IFN-~ was unaltered by HDV (Table 1) .
Interferon induction
Attempts to induce the expression of IFN-fl in Huh7 or Huh7-derived clones with dsRNA and Sendal virus were unsuccessful. Cells were treated with poly(rI).poly(rC) at the standard concentration of 0-l mg/ml in serum-free medium for 1 to 6 h but no IFN-//expression was evident on RNase protection analysis. Priming the cells with IFN-e at 100 IU/ml overnight and cycloheximide treatment, both of which normally enhance the response to poly(rI).poly(rC), were without effect. Treatment of HT1080 cells under the same conditions successfully induced IFN-fl mRNA (data not shown).
In order to establish whether HDV RNA or delta Ag expression affects the induction of IFN-~, the HDVexpressing fibrosarcoma clones, HT.D3(1) and HT.D3 (2), and an additional HT1080-derived clone (HT.Ag-S) which expressed delta Ag alone, were examined. Expression of HDV RNA and/or delta Ag was confirmed by RNase protection and/or immunoblotting. Treatment of HT.D3(1), HT.D3(2) and HT. Ag-S with poly(rI), poly(rC) at 0.1 mg/ml for 2 h induced the expression of IFN-fl mRNA to the same level as in the parental HT1080 cells (Fig. 4a) . The induction of another dsRNA-inducible gene, IRF-1, was also normal in the HDV-expressing cells. Unlike the parental and delta Ag-expressing cell lines, both HT. D3(1) and HT. D3(2) expressed a significant constitutive level of IFN-fl [shown for HT. D3(1) in Fig. 4b ]. This may reflect the presence of a low level of unmasked dsRNA in cells expressing HDV RNA or it may be due to lysis of some of the cells, with release of HDV RNA into the medium where it becomes ds. To examine the latter possibility, clones HT. D3(1) and HT. D3(2) were co-cultivated with mouse fibroblast C127 cells for 48 h. The induction of mouse IFN-fl mRNA in the C127 cells was then determined by RNase protection. There was no evidence of IFN-fl mRNA expression in the mouse cells. However, the concentration of dsRNA released from lysed HDV-transfected cells may be very low and mouse C127 cells are less sensitive to exposure to dsRNA than human fibrosarcoma cells.
Exposure of HT1080 to dsRNA for prolonged periods (6 h or more) was shown to render the IFN-fl mRNA response refractory to further treatment with dsRNA (Fig. 4c) . It would therefore be expected that the HT. D3 clones would fail to respond to poly(rI), poly(rC) if they were persistently expressing an RNA species which was unmasked and ds; this was clearly not the case (Fig. 4 a) .
To examine the possibility that HDV RNA is masked by binding of the delta Ag, HT1080 clones which expressed HDV RNA in the absence of delta Ag were derived by transfection with the constructs pCMV. D2M and pRSV. D2M. RNase protection confirmed that these clones expressed HDV RNA to a level comparable to cells treated for 6 h, allowed to recover for 2 h and re-treated with poly(rI).poly(rC) for 2 h. Assays were by RNase protection, A probe for 7-actin mRNA was included to provide a loading control. The size in nucleotides of the markers (lane M) is indicated to the left. that in HT. D3(1) and HT. D3(2). IFN-fl mRNA was not expressed constitutively and was normally inducible in these cells (data not shown).
P K R assays
The lack of effect of IFN-~ and IFN-y treatment on the level of expression of delta Ag in H7. D cells (Fig. 2) suggests that either PKR is not activated by the presence of HDV RNA or the virus is able to inhibit the function of this enzyme. In vitro PKR assays were therefore performed using cellular extracts from the HT. D3 cell lines. Autophosphorylation of the 68K PKR in response to dsRNA was unaltered in the HT. D3 cells, compared to the parental HT1080, and there was no consistent evidence of significant constitutive activity of this enzyme (Fig. 5) . The slightly lower inducibility of PKR apparent in HT.D3(1) cells compared with HT1080 cells in the absence of IFN and the slightly higher level with IFN, but minus dsRNA (Fig. 5) , were not consistently observed and are likely to reflect slight differences in loading. Phosphorylation of the 68K protein was much weaker in cell extracts from Huh7 and H7.D and the results in these cells were therefore inconclusive.
Discussion
Prolonged IFN treatment of cell lines transfected with an HDV eDNA trimer does not influence the level of expression of HDV RNA or delta Ag ( Fig. 1 and 2 ). This is consistent with a failure of activation of the IFNinducible enzymes 2',5'A synthetase and PKR. This could arise through an inhibition of the cellular response to IFN by a product of HDV, but the transcriptional induction of several IFN-inducible genes, including 2',5'A synthetase and PKR, is normal (Fig. 3) . The IFNinduced antiviral response of HDV-expressing cells to two cytopathic viruses, EMC and SFV, is intact (Table  1) . Since IFN is known to protect cells against the cytopathic effects of EMC, at least in part, by activating 2',5'A synthetase (Silverman et al., 1982b) , this assay also provides an alternative index of the activity of the 2',5'A synthetase system. The results suggest that this system is unaffected by HDV expression. The activation of PKR is also unaffected by HDV (Fig. 5) as is the inducibility of IFN-fl (Fig. 4) . The expression of a low constitutive level of IFN-fl in HDV-transfected cells may reflect the presence of a low level of unmasked dsRNA in these cells. Alternatively, release of HDV RNA from lysed cells may allow it to become ds in the medium and induce IFN-fl in neighbouring cells. IFN-fl was not expressed in co-cultivated mouse cells, but this may reflect the different sensitivity of these cells. It does not, therefore, exclude low level lysis as the reason for IFN induction in the HDV-transfected fibrosarcoma cells. Since cells exposed to dsRNA for prolonged periods fail to express IFN-fl on re-exposure to dsRNA and the HDV-transfected cells retain their response to poly(rI), poly(rC), it is unlikely that they are expressing significant amounts of unmasked dsRNA. The failure of HDV RNA to alter significantly the inducibility of IFN-fl (Fig. 4) or the activation of PKR (Fig. 5) suggests that the HDV RNA is masked or does not have significant secondary structure in the cytoplasm, i.e. is predominantly ss. The delta Ag, which has been shown to bind to specific subregions of the genomic and antigenomic HDV RNAs (Chao et al., 1991) , may be able to prevent the RNA interacting with the dsRNAdependent enzymes. However, expression of HDV RNA in the absence of the delta Ag does not induce IFN-fl nor affect its induction by exogenous dsRNA. It is possible that HDV RNA exists in a ds form only in cellular compartments that are separated from factors responsible for IFN induction.
The exact structure of HDV RNA in vivo remains in doubt. It is unlikely that the high degree of nucleotide complementarity of the HDV genome has been retained unless it is indeed ds at some stage in the viral life cycle, although it may only exist in this form when packaged into viral particles. Examination of HDV-infected human and woodchuck liver by in situ hybridization suggested that the genomic RNA is around 30 times more abundant than antigenomic. Unlike the genomic RNA, the antigenomic RNA was only detectable using conditions that would denature dsRNA (Gowans et al., 1988) . Therefore, the antigenomic RNA appears to exist mainly in a ds form as a result of base-pairing with genomic RNA, presumably representing replicative forms of HDV RNA. Gowans et al. (1988) concluded that extensive self-annealing of HDV RNA does not occur in vivo. A separate study (Chen et al., 1986) found that a significant proportion of antigenomic RNA was resistant to digestion with RNase and again concluded that this was due to complexing with genomic RNA rather than self-annealing, since the protected RNA fragments were equivalent to one and two complete genome-lengths (1.7kb and 3"5kb). However, S1 nuclease digestion of virion and genomic liver RNA released a heterogeneous distribution of fragments consistent with a degree of protection from nuclease digestion as a result of self-annealing of the RNA. It is difficult to exclude the possibility that the dsRNA species isolated in these studies are artefacts of RNA preparation.
There 
